Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fukun Guo

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2010
Coordination of IL-7 receptor and T-cell receptor signaling by cell-division cycle 42 in T-cell homeostasisFukun Guo, David Hildeman, Pulak Tripathi, et al.
Blood|February 25, 2010
Rac1 targeting suppresses p53 deficiency-mediated lymphomagenesisEmily E Bosco, Wenjun Ni, Lei Wang, et al.
Cell Cycle (Georgetown, Tex.)|November 19, 2005
Constitutively active Cdc42 mutant confers growth disadvantage in cell transformationCristina Vanni, Catherine Ottaviano, Fukun Guo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2018
Reciprocal Regulation of Glycolysis-Driven Th17 Pathogenicity and Regulatory T Cell Stability by Cdc42Khalid W Kalim, Jun-Qi Yang, Yuan Li, et al.
Frontiers in Cell and Developmental Biology|October 25, 2021
Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint InhibitorsXiaoying Li, Yueyao Yang, Qian Huang, et al.
Blood|December 8, 2009
Rho GTPases in hematopoiesis and hemopathiesJames C Mulloy, Jose A Cancelas, Marie-Dominique Filippi, et al.
Plos One|August 17, 2017
mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activityKhalid W Kalim, Shuangmin Zhang, Xiaoyi Chen, et al.
Frontiers in Immunology|November 1, 2021
Graded RhoA GTPase Expression in Treg Cells Distinguishes Tumor Immunity From AutoimmunityKhalid W Kalim, Jun-Qi Yang, Vishnu Modur, et al.
Frontiers in Oncology|October 22, 2019
Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple MyelomaPhuong Nguyen, Jayati Chakrabarti, Yuan Li, et al.
Stem Cells (Dayton, Ohio)|October 26, 2018
mDia1 and Cdc42 Regulate Activin B-Induced Migration of Bone Marrow-Derived Mesenchymal Stromal CellsXueer Wang, Pei Tang, Fukun Guo, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2010
Coordination of IL-7 receptor and T-cell receptor signaling by cell-division cycle 42 in T-cell homeostasisFukun Guo, David Hildeman, Pulak Tripathi, et al.
Blood|February 25, 2010
Rac1 targeting suppresses p53 deficiency-mediated lymphomagenesisEmily E Bosco, Wenjun Ni, Lei Wang, et al.
Cell Cycle (Georgetown, Tex.)|November 19, 2005
Constitutively active Cdc42 mutant confers growth disadvantage in cell transformationCristina Vanni, Catherine Ottaviano, Fukun Guo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2018
Reciprocal Regulation of Glycolysis-Driven Th17 Pathogenicity and Regulatory T Cell Stability by Cdc42Khalid W Kalim, Jun-Qi Yang, Yuan Li, et al.
Frontiers in Cell and Developmental Biology|October 25, 2021
Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint InhibitorsXiaoying Li, Yueyao Yang, Qian Huang, et al.
Blood|December 8, 2009
Rho GTPases in hematopoiesis and hemopathiesJames C Mulloy, Jose A Cancelas, Marie-Dominique Filippi, et al.
Plos One|August 17, 2017
mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activityKhalid W Kalim, Shuangmin Zhang, Xiaoyi Chen, et al.
Frontiers in Immunology|November 1, 2021
Graded RhoA GTPase Expression in Treg Cells Distinguishes Tumor Immunity From AutoimmunityKhalid W Kalim, Jun-Qi Yang, Vishnu Modur, et al.
Frontiers in Oncology|October 22, 2019
Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple MyelomaPhuong Nguyen, Jayati Chakrabarti, Yuan Li, et al.
Stem Cells (Dayton, Ohio)|October 26, 2018
mDia1 and Cdc42 Regulate Activin B-Induced Migration of Bone Marrow-Derived Mesenchymal Stromal CellsXueer Wang, Pei Tang, Fukun Guo, et al.
Pageof 7